Tessera Therapeutics is developing a genome engineering technology, Gene Writing™. The goal of Gene Writing™ is to be able to make genomic alterations that can be used to treat or cure disease. Tessera Therapeutics was founded in 2018 by Geoffrey von Maltzahn Ph.D., Jacob Rubens, Ph.D., and Noubar Afeyan, Ph.D. and is headquartered in Cambridge, MA.

Register for Details

For more details on financing and valuation for Tessera, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

What is Tessera's ticker symbol?

Tessera does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

What is Tessera's stock price?

The stock price for Tessera will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Who are Tessera's major investors?

ARTIS Ventures
Toba Capital
Flagship Pioneering
March Capital
TA Ventures
Longevity Vision Fund

Tessera Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
4/19/2022 Series C $300MM raised $XXX.XX $XXX.XX
1/12/2021 Series B $232.5MM raised $XXX.XX $XXX.XX
7/7/2020 Series A, A-1, and A-2 $26.41MM raised $XXX.XX $XXX.XX
Based on primary financings
Powered by Forge Data

Learn more about Tessera

Forge green plus iconForge green minus icon

What is Tessera funding to date?

Tessera has raised $558.91MM with the following series:
$26.41MM raised for Series A, A-1, and A-2,$232.5MM raised for Series B,$300MM raised for Series C.
Forge green plus iconForge green minus icon

When was Tessera founded?

Tessera was founded in 2018.
Forge green plus iconForge green minus icon

Can you invest in Tessera?

Tessera is a privately held company and is not publicly traded on NYSE or NASDAQ in the U.S. To buy pre-IPO shares of a private company, you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Forge green plus iconForge green minus icon

Can you sell Tessera share pre-IPO?

If you own Tessera pre-IPO shares and are considering selling, you can find what your shares could be worth on Forge’s secondary marketplace.

Our Private Market Specialists are available to answer any questions you might have and can help connect you with a buyer from our network of 125,000 accredited investors and institutions. You can also learn more about how to sell your private shares before getting started.

Forge green plus iconForge green minus icon

Is Tessera a publicly traded company?

Tessera is a private company and not publicly traded.

If you are interested in buying or selling private company shares, you can register with Forge today for free to explore your options. Registering gives you access to one of our Private Market Specialists who can guide you through the process of buying or selling. Learn more about how Forge might help you buy pre-IPO shares or sell pre-IPO shares.

Other companies like Tessera in the Healthcare sector

Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$809.52MM
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$396.01MM
Sector
Last Round Est. Valuation
$400.53MM
Sector
Last Round Est. Valuation
$1.53B